A distinct glycoform of CD44 is an L-selectin ligand on human hematopoietic cells.

Proc Natl Acad Sci U S A

Department of Medicine and Dermatology, Brigham and Women's Hospital and Harvard Skin Disease Research Center, Harvard Medical School, Massachusetts General Hospital, Boston, MA 02115, USA.

Published: December 2000

We previously have obtained operational evidence of a hematopoietic cell L-selectin ligand expressed on normal human hematopoietic cells and on leukemic blasts. Using a technique developed in our laboratory for analyzing and identifying adhesion molecules, we show here that hematopoietic cell L-selectin ligand is a specialized glycoform of CD44. This L-selectin ligand activity of CD44 requires sialofucosylated N-linked glycans and is sulfation-independent. These data provide important insights on the structural biology of CD44 and reveal a role for this protein as an L-selectin ligand on human hematopoietic cells.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC17663PMC
http://dx.doi.org/10.1073/pnas.250484797DOI Listing

Publication Analysis

Top Keywords

l-selectin ligand
20
human hematopoietic
12
hematopoietic cells
12
glycoform cd44
8
cd44 l-selectin
8
ligand human
8
hematopoietic cell
8
cell l-selectin
8
l-selectin
5
ligand
5

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!